# S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer

> **NCT00118105** · PHASE2 · WITHDRAWN · sponsor: **SWOG Cancer Research Network**

## Conditions studied

- Colorectal Cancer
- Metastatic Cancer

## Interventions

- **BIOLOGICAL:** bevacizumab
- **DRUG:** capecitabine
- **DRUG:** oxaliplatin
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00118105
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-11
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Budget Constraints
- **Last updated:** 2013-01-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00118105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00118105, "S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00118105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*